Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Patient Education 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Genital Neoplasms, Female 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Delirium 1Cigarette Smoking-Related Carcinoma 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma 1Adenocarcinoma 1

Interventions

suvorexant 1Therapeutics 1Standard of Care 1Practice Guidelines as Topic 1Patient Portals 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Sleep Initiation and Maintenance Disorders × Interviews as Topic × Clear all
NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Mayo Clinic

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡